Genetically engineered maize: risks not under control

Companies disregarding EU regulation
Thursday, 24 November 2016

The EU Commission wants to allow the cultivation of genetically engineered maize before the growing season 2017 starts. Three variants of transgenic maize producing insecticidal toxins, registered as MON810, Maize 1507 and Bt 11, are being considered. Monsanto, DuPont/Pioneer and Syngenta are pushing for the market introduction of the seeds. EU Member States are expected to vote on this issue on 9 December.

Independent scientists set up international research project

The project focus: Risks of genetically engineered plants
Wednesday, 16 November 2016

A new project dealing with the risks of genetically engineered plants was set up this week during a workshop in Zürich, Switzerland. The project is independent of the interests of the biotech industry. The experts from the public sector and civil society agree that current regulatory practise as applied in risk assessment of genetically engineered plants in Europe is not sufficient to safeguard the protection of health and the environment.

Nobel Prize laureates unknowingly caught up in sales campaign for a biotech company?

Initiator of an appeal for the cultivation of genetically engineered rice is chief scientific officer of a company profiting from the production of genetically engineered plants

7 November 2016 / In June 2016, more than 100 Nobel Prize laureates signed an appeal in favour of the cultivation of so-called Golden Rice. Initiated by Sir Richard Roberts, who was awarded the Nobel Prize for Medicine in 1993, it targets and criticises anyone against the release of genetically engineered plants. For many years now, Roberts has been the chief scientific officer of New England Biolabs. Big corporates such as Monsanto, Syngenta and Dow AgroSciences are all clients of New England Biolabs.


Subscribe to testbiotech RSS